- Home
- CASI vs KORE Comparison
CASI vs KORE Comparison
Compare CASI & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- KORE
- Stock Information
- Founded
- CASI 1991
- KORE 2003
- Country
- CASI China
- KORE United States
- Employees
- CASI N/A
- KORE N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- KORE Telecommunications Equipment
- Sector
- CASI Health Care
- KORE Consumer Discretionary
- Exchange
- CASI Nasdaq
- KORE Nasdaq
- Market Cap
- CASI 35.0M
- KORE 39.8M
- IPO Year
- CASI 1996
- KORE N/A
- Fundamental
- Price
- CASI $2.21
- KORE $2.45
- Analyst Decision
- CASI Strong Buy
- KORE Buy
- Analyst Count
- CASI 1
- KORE 2
- Target Price
- CASI $6.00
- KORE $10.00
- AVG Volume (30 Days)
- CASI 8.1K
- KORE 21.3K
- Earning Date
- CASI 03-27-2025
- KORE 04-10-2025
- Dividend Yield
- CASI N/A
- KORE N/A
- EPS Growth
- CASI N/A
- KORE N/A
- EPS
- CASI N/A
- KORE N/A
- Revenue
- CASI $22,055,000.00
- KORE $285,229,000.00
- Revenue This Year
- CASI N/A
- KORE $3.89
- Revenue Next Year
- CASI $134.79
- KORE $5.35
- P/E Ratio
- CASI N/A
- KORE N/A
- Revenue Growth
- CASI N/A
- KORE 7.01
- 52 Week Low
- CASI $2.04
- KORE $1.10
- 52 Week High
- CASI $7.67
- KORE $4.88
- Technical
- Relative Strength Index (RSI)
- CASI 35.91
- KORE 51.48
- Support Level
- CASI $2.15
- KORE $2.31
- Resistance Level
- CASI $2.49
- KORE $2.60
- Average True Range (ATR)
- CASI 0.15
- KORE 0.18
- MACD
- CASI 0.00
- KORE -0.01
- Stochastic Oscillator
- CASI 35.42
- KORE 59.02
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.